Package Leaflet:information for the patient
Xigduo 5mg/850mg film-coated tablets
Xigduo 5mg/1,000mg film-coated tablets
dapagliflozin/metformin hydrochloride
Read all of this leaflet carefully before you start takingthismedicine, because it contains important information for you.
Contents of the pack
This medicine contains two different active substances called dapagliflozin and metformin. Both belong to a group of medicines called “oral antidiabetics”. These are medicines that you take by mouth to treat diabetes.
Xigduo is used to treat a type of diabetes called “type 2 diabetes” in adult patients (aged 18 years or older) and that normally appears when you are older. If you have type 2 diabetes, your pancreas does not produce enough insulin or your body is not able to use the insulin it produces properly. This leads to a high level of sugar (glucose) in your blood.
To treat diabetes:
It is important that you continue to follow the dietary and exercise recommendations given to you by your doctor, pharmacist, or nurse.
Do not take Xigduo:
Do not take this medicine if any of the above applies to you.
Warnings and precautions
Risk of lactic acidosis
Xigduo may cause a very rare but very serious side effect called lactic acidosis, especially if your kidneys are not working properly. The risk of developing lactic acidosis is also increased with uncontrolled diabetes, severe infections, prolonged fasting or alcohol consumption, dehydration (see more information below), liver problems, and any medical condition in which a part of your body has a reduced supply of oxygen (such as acute and severe heart disease).
If any of the above applies to you, consult your doctor for further instructions.
Stop taking Xigduo for a short period if you have a condition that may be associated with dehydration(significant loss of body fluids), such as severe vomiting, diarrhea, fever, heat exposure, or if you drink less fluid than usual. Consult your doctor for further instructions.
Stop taking Xigduo and contact a doctor or the nearest hospital immediately if you experience any of the symptoms that lactic acidosis produces,as this condition can lead to a coma.
The symptoms of lactic acidosis include:
Lactic acidosis is a medical emergency and should be treated in a hospital.
Consult your doctor quickly if:
Experiences any of the following symptoms after starting treatment with metformin: convulsions, cognitive impairment, difficulty with body movements, symptoms indicative of nerve damage (e.g., pain or numbness), migraine, and hearing loss.
Consult your doctor, pharmacist, or nurse before starting Xigduo and during treatment:
If you need to undergo major surgery, you should stop taking Xigduo during the procedure and for a period after it. Your doctor will decide when you should stop taking Xigduo and when you can restart it.
It is important that you regularly check your feet and follow any other foot care advice given to you by your healthcare professional.
If any of the above applies to you (or you are not sure), talk to your doctor, pharmacist, or nurse before taking this medicine.
Consult your doctor immediately if you experience a combination of symptoms of pain, tenderness, redness, or swelling of the genitals or the area between the genitals and the anus, with fever or general feeling of being unwell. These symptoms could be a sign of a rare but serious, potentially life-threatening infection called necrotizing fasciitis of the perineum or Fournier's gangrene, which destroys tissue under the skin. Fournier's gangrene should be treated immediately.
Kidney function
During treatment with Xigduo, your doctor will check your kidney function at least once a year or more frequently if you are an older person and/or if your kidney function is worsening.
Glucose in urine
Due to how this medicine works, your urine will test positive for glucose while you are taking this medicine.
Children and adolescents
This medicine is not recommended for children and adolescents under 18 years of age, as it has not been studied in these patients.
Other medicines and Xigduo
If you need to be given an injection of a contrast medium that contains iodine into your bloodstream, for example, in the context of an X-ray or scan, you should stop taking Xigduo before or at the time of the injection. Your doctor will decide when you should stop taking Xigduo and when you can restart it.
Tell your doctor if you are taking, have recently taken, or might take any other medicines. You may need more frequent blood glucose and kidney function tests, or your doctor may need to adjust the dose of Xigduo. It is especially important to mention the following:
Taking Xigduo with alcohol
Avoid excessive alcohol consumption while taking Xigduo, as this may increase the risk of lactic acidosis (see section “Warnings and precautions”).
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. You should stop taking this medicine if you become pregnant, as it is not recommended during the second and third trimesters of pregnancy (the last six months). Consult your doctor about the best way to control your blood sugar during pregnancy.
Consult your doctor if you want to breastfeed or are breastfeeding before taking this medicine. You should not use this medicine during breastfeeding. Metformin passes into breast milk in small amounts. It is not known if dapagliflozin passes into breast milk.
Driving and using machines
This medicine has no or negligible influence on the ability to drive and use machines. Taking it with other medicines that lower the amount of sugar in the blood, such as insulin or a “sulfonylurea” type medicine, may cause low blood sugar levels (hypoglycemia), which can cause symptoms such as weakness, dizziness, increased sweating, rapid heartbeat, vision changes, or difficulty concentrating, which can affect your ability to drive or use machines. Do not drive or use tools or machines if you start to feel these symptoms.
Sodium content
This medicine contains less than 1 mmol of sodium (23 mg) per dose, which is essentially “sodium-free”.
Follow exactly the instructions of administration of this medicine given to you by your doctor. In case of doubt, consult your doctor or pharmacist again.
How much to take
How to take this medicine
Your doctor may prescribe this medicine for you to take with another medicine(s) to lower the amount of sugar in your blood. These may be medicine(s) taken by mouth or given by injection, such as insulin or a GLP-1 receptor agonist. Remember to take these other medicine(s) as instructed by your doctor. This will help you get the best results for your health.
Diet and exercise
To control your diabetes, you should continue with diet and exercise, even when taking this medicine. Therefore, it is important that you continue to follow the dietary and exercise recommendations given to you by your doctor, pharmacist, or nurse. In particular, if you are following a weight-control diet for diabetics, continue with it while taking this medicine.
If you take more Xigduo than you should
If you take more Xigduo tablets than you should, you may experience lactic acidosis. The symptoms of lactic acidosis include having a lot of nausea or vomiting, stomach pain, muscle cramps, intense fatigue, or difficulty breathing. If this happens to you, you may need immediate hospital treatment, as lactic acidosis can lead to a coma. Stop taking this medicine immediately and contact a doctor or the nearest hospital right away (see section 2). Bring the medicine pack with you.
If you forget to take Xigduo
If you forget a dose, take it as soon as you remember. If you do not remember until it is time for your next dose, skip the missed dose and follow your regular schedule. Do not take a double dose of this medicine to make up for missed doses.
If you stop taking Xigduo
Do not stop taking this medicine without talking to your doctor first. Your blood sugar levels may increase without this medicine.
If you have any further questions on the use of this medicine, ask your doctor, pharmacist, or nurse.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
Stop taking Xigduo and consult a doctor immediately if you notice any of these serious or potentially serious adverse effects:
Xigduo may cause a very rare but very serious adverse effect called lactic acidosis (see section 2 “Warnings and Precautions”). If this happens to you, you must stop taking Xigduo and contact a doctor or the nearest hospital immediately, as lactic acidosis can lead to coma.
Contact a doctor or the nearest hospital immediately if you experience any of the following adverse effects:
These are the signs of diabetic ketoacidosis (see also section 2 “Warnings and Precautions”):
This can occur despite blood glucose levels. Your doctor should decide whether to temporarily or permanently interrupt your treatment with Xigduo.
Stop taking Xigduo and consult a doctor as soon as possible if you notice any of the following serious or potentially serious adverse effects:
These are the signs of a serious urinary tract infection:
Although it is rare, if you notice blood in your urine, inform your doctor immediately.
Contact a doctor as soon as possible if you experience any of the following adverse effects:
The signs of low blood sugar are:
Your doctor will explain how to treat low blood sugar levels and what to do if you experience any of the above symptoms. If you have symptoms of low blood sugar, take glucose tablets, a sugary snack, or drink a fruit juice. Measure your blood sugar level, if possible, and rest.
Other adverse effects include:
Very common
Common
Uncommon(may affect up to 1 in 100 people)
Rare
Reporting Adverse Effects
If you experience any adverse effects, consult your doctor, pharmacist, or nurse, even if they are possible adverse effects not listed in this leaflet. You can also report them directly through the national reporting system included in Appendix V.
By reporting adverse effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of sight and reach of children.
Do not use this medicine after the expiration date stated on the blister or packaging after EXP/CAD. The expiration date is the last day of the month indicated.
No special storage conditions are required.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of the packaging and any unused medicines. This will help protect the environment.
Xigduo Composition
Each film-coated tablet (tablet) of Xigduo 5 mg/850 mg contains dapagliflozin propanediol monohydrate equivalent to 5 mg of dapagliflozin and 850 mg of metformin hydrochloride
Each film-coated tablet (tablet) of Xigduo 5 mg/1,000 mg contains dapagliflozin propanediol monohydrate equivalent to 5 mg of dapagliflozin and 1,000 mg of metformin hydrochloride
Product Appearance and Package Contents
Xigduo 5 mg/850 mg film-coated tablets and Xigduo 5 mg/1,000 mg film-coated tablets are available in PVC/PCTFE/Alu blisters. The package sizes are 14, 28, 56, and 60 film-coated tablets in non-perforated blisters, 60x1 film-coated tablets in perforated unit-dose blisters, and multiple packages of 196 (2 packages of 98) film-coated tablets in non-perforated blisters
Not all package sizes may be marketed in your country
Marketing Authorization Holder
AstraZeneca AB
SE-151 85 Södertälje
Sweden
Manufacturer
AstraZeneca AB
Gärtunavägen
SE-152 57 Södertälje
Sweden
You can request more information about this medicine by contacting the local representative of the marketing authorization holder:
België/Belgique/Belgien AstraZeneca S.A./N.V. Tel: +32 2 370 48 11 | Lietuva UAB AstraZeneca Lietuva Tel: +370 5 2660550 Luxembourg/Luxemburg AstraZeneca S.A./N.V. Tél/Tel: +32 2 370 48 11 |
Ceská republika AstraZeneca Czech Republic s.r.o. Tel: +420 222 807 111 | Magyarország AstraZeneca Kft. Tel.: +36 1 883 6500 |
Danmark AstraZeneca A/S Tlf.: +45 43 66 64 62 | Malta Associated Drug Co. Ltd Tel: +356 2277 8000 |
Deutschland AstraZeneca GmbH Tel: +49 40 809034100 | Nederland AstraZeneca BV Tel: +31 85 808 9900 |
Eesti AstraZeneca Tel: +372 6549 600 | Norge AstraZeneca AS Tlf: +47 21 00 64 00 |
Ελλáδα AstraZeneca A.E. Τηλ: +30 2 106871500 | Österreich AstraZeneca Österreich GmbH Tel: +43 1 711 31 0 |
España AstraZeneca Farmacéutica Spain, S.A. Tel: +34 91 301 91 00 | Polska AstraZeneca Pharma Poland Sp. z o.o. Tel.: +48 22 245 73 00 |
France AstraZeneca Tél: +33 1 41 29 40 00 | Portugal AstraZeneca Produtos Farmacêuticos, Lda. Tel: +351 21 434 61 00 |
Hrvatska AstraZeneca d.o.o. Tel: +385 1 4628 000 | România AstraZeneca Pharma SRL Tel: +40 21 317 60 41 |
Ireland AstraZeneca Pharmaceuticals (Ireland) DAC Tel: +353 1609 7100 | Slovenija AstraZeneca UK Limited Tel: +386 1 51 35 600 |
Ísland Vistor Sími: +354 535 7000 | Slovenská republika AstraZeneca AB, o.z. Tel: +421 2 5737 7777 |
Italia AstraZeneca S.p.A. Tel: +39 02 00704500 | Suomi/Finland AstraZeneca Oy Puh/Tel: +358 10 23 010 |
Κúπρος ΑλÉκτωρ Φαρµακευτικn Λτδ Τηλ: +357 22490305 | Sverige AstraZeneca AB Tel: +46 8 553 26 000 |
Latvija SIA AstraZeneca Latvija Tel: +371 67377100 |
Date of Last Revision of this Leaflet:
Other Sources of Information
Detailed information about this medicine is available on the European Medicines Agency website: http://www.ema.europa.eu
The average price of XIGDUO 5 mg/850 mg FILM-COATED TABLETS in October, 2025 is around 49.83 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.